Agile Therapeutics Reports First Quarter 2022 Financial

Twirla Experienced Another Quarter of Double-Digit Demand Growth in First Quarter 2022 Twirla Business Plan Progressing Company Anticipates Future 2022...

Related Keywords

California ,United States ,New Jersey ,Afaxys Pharma ,Matt Riley ,Al Altomari ,Head Of Investor Relations Corporate Communications ,Nasdaq ,Exchange Commission ,Agile Therapeutics Inc ,Company Anticipates ,Securities Exchange ,Symphony Health Solutions ,Double Digit Demand Growth ,First Quarter ,Anticipates Future ,Operating Expenses ,Host Conference Call Today ,Agile Therapeutics Chairman ,Recent Corporate ,Work Down Debt Facility ,Perceptive Advisors ,Regain Compliance ,Nasdaq Stock Market ,Raise Additional Capital ,Reverse Stock Split ,Nasdaq Capital Market ,New Jersey Net Operating Losses ,Investor Relations ,About Agile Therapeutics ,Symphony Health ,Cycles Dispensed ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Reports ,Nasdaq Agrx ,Agile Therapeutics ,Nc ,